Stoky
Back to explore
N
NoahListening
A
AshListening
0:00 / 0:00I. Financial Performance and Results of Operations
ZBH logo

Zimmer Biomet's Q1 Sales Rise 1.1% to $1.9B Amid Acquisition Push

ZBH10-QFiling Date: 5/5/2025
Zimmer Biomet Holdings, Inc.
Description

What this story covers

Zimmer Biomet reported Q1 net sales of $1.9B, up 1.1%, with earnings at $182M. Growth driven by volumes in orthopedics, offset by currency; Paragon 28 acquisition expands foot/ankle portfolio. Strong liquidity supports restructuring for $95M+ savings; risks include tariffs and competition.

Story snapshot

CompanyZimmer Biomet Holdings, Inc.
TickerZBH
VariantStandard detailed
Duration10:16
Filing type10-Q
PeriodQ1 2025
IndustryHealthcare & Pharmaceuticals
Accession0000950170-25-063509

Full Story Script

Content not available for this story.

Ask Noah

Question the story, source filings, and key financial signals.

Sign in to chat with Noah

Ask questions about revenue, margins, risk factors, filings and more. Noah uses retrieval-augmented analysis over raw financial disclosures.

Sign in